Skip to content

COVID-19 Response Inquiry’s focus on solutions like a Centre for Disease Control – not blame – is right approach: Public Health peak

By API User

29 October 2024 Australia’s peak body for Public Health has responded to the COVID-19 Response Inquiry report, saying that the emphasis on an Australian Centre for Disease Control is the correct approach to help the country prepare for future infectious disease outbreaks, as well as the persistent challenges of non-communicable diseases. “As the COVID-19 outbreak … Continued

LTR Pharma Limited (ASX:LTP) – September 2024 Quarterly Activities Report

By API User

LTR Pharma Limited (ASX:LTP) (“LTR Pharma”, “the Company”), a Company focused on improving men’s health through clinical development and commercialisation of an innovative nasal spray treatment for erectile dysfunction (“ED”), SPONTAN®, is pleased to provide its Appendix 4C for the quarter ended 30 September 2024. Highlights: SPONTAN® prescribed to first patients under the Therapeutic Goods … Continued

New Australian Cardiovascular Alliance Collaboration Unites Health Leaders and Researchers to Drive National Action on Cardiovascular Disease and Stroke Priorities

By API User

Cardiovascular disease (CVD) remains a leading cause of death and disability in Australia. While this burden can seem overwhelming, the nation’s cardiovascular leaders believe that with improved coordination and pathways for prioritised translation our talented researchers can make substantial impacts on prevention, early disease detection and treatment.   Addressing this pressing challenge, the Cardiovascular Health … Continued

Improving the care of mothers between pregnancies

By API User

Some Australian mothers regard navigating their personal health care in between pregnancies as confusing, inconsistent, and hard to access, new research by a Monash University-led team has found. The focus of consultations between pregnancies is mostly on babies and children, while the health needs of mothers can be neglected with potentially negative consequences for women … Continued

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

By API User

The acquisition expands Organon’s dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. JERSEY CITY, N.J.–BUSINESS WIRE– Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced the successful completion of its acquisition of Dermavant Sciences Ltd. from Roivant (NASDAQ: ROIV). Dermavant … Continued

BeiGene Mourns Death of Beloved Board Member Donald Glazer

By API User

SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is saddened to share the news that Donald Glazer recently passed away. Don was a Board member and the chair of the nominating and corporate governance committee. Co-founder, Chairman and CEO John V. Oyler issued the following statement: “We … Continued

ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

By API User

Collaboration will expand access to high sensitivity NULISA immunoassays for clinical biomarker analysis. GENT, Belgium & FREMONT, Calif.–BUSINESS WIRE– ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies, today announced a partnership in the development of customized biomarker assay … Continued